Cargando…

Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity

Chikungunya virus (CHIKV) is an arthropod-borne alphavirus that causes hallmark debilitating polyarthralgia, fever, and rash in patients. T cell-mediated immunity, especially CD4(+) T cells, are known to participate in the pathogenic role of CHIKV immunopathology. The other T cell subsets, notably C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poh, Chek Meng, Chan, Yi-Hao, Ng, Lisa F. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046835/ https://www.ncbi.nlm.nih.gov/pubmed/32153590 http://dx.doi.org/10.3389/fimmu.2020.00287

Ejemplares similares

Co‐infection with Chikungunya virus alters trafficking of pathogenic CD8(+) T cells into the brain and prevents Plasmodium‐induced neuropathology
por: Teo, Teck‐Hui, et al.
Publicado: (2017)

Limitations of Current in Vivo Mouse Models for the Study of Chikungunya Virus Pathogenesis
por: Chan, Yi-Hao, et al.
Publicado: (2015)

Editorial: Porcine Anti-Viral Immunity
por: Vlasova, Anastasia N., et al.
Publicado: (2020)

Regulatory T-cells and GARP expression are decreased in exercise-associated chikungunya viral arthritis flares
por: Dobbs, John E., et al.
Publicado: (2022)

Construction and immunogenicity of an mRNA vaccine against chikungunya virus
por: Liu, Jingjing, et al.
Publicado: (2023)

Porcine Anti-viral Immunity: How Important Is It?
por: Lager, Kelly M., et al.
Publicado: (2019)

Chikungunya Virus Infection Results in Higher and Persistent Viral Replication in Aged Rhesus Macaques Due to Defects in Anti-Viral Immunity
por: Messaoudi, Ilhem, et al.
Publicado: (2013)

Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections
por: Schrauf, Sabrina, et al.
Publicado: (2020)

Neutrophil Extracellular Traps Effectively Control Acute Chikungunya Virus Infection
por: Hiroki, Carlos H., et al.
Publicado: (2020)

Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus
por: Kaushik, Sulochana, et al.
Publicado: (2020)

Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate
por: Prow, Natalie A., et al.
Publicado: (2019)

Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease
por: Broeckel, Rebecca M., et al.
Publicado: (2019)

Involvement of the TRPML Mucolipin Channels in Viral Infections and Anti-viral Innate Immune Responses
por: Santoni, Giorgio, et al.
Publicado: (2020)

The trinity of COVID-19: immunity, inflammation and intervention
por: Tay, Matthew Zirui, et al.
Publicado: (2020)

Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential
por: Webb, Emily M., et al.
Publicado: (2019)

Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases
por: Iizasa, Hisashi, et al.
Publicado: (2020)

P38 and JNK Mitogen-Activated Protein Kinases Interact With Chikungunya Virus Non-structural Protein-2 and Regulate TNF Induction During Viral Infection in Macrophages
por: Nayak, Tapas Kumar, et al.
Publicado: (2019)

The Aryl Hydrocarbon Receptor as a Modulator of Anti-viral Immunity
por: Torti, Maria Florencia, et al.
Publicado: (2021)

IFITs: Emerging Roles as Key Anti-Viral Proteins
por: Vladimer, Gregory I., et al.
Publicado: (2014)

HCMV carriage in the elderly diminishes anti-viral functionality of the adaptive immune response resulting in virus replication at peripheral sites
por: Davies, Emma L., et al.
Publicado: (2022)

Corrigendum: Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases
por: Iizasa, Hisashi, et al.
Publicado: (2020)

Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus
por: Gushchin, Vladimir A., et al.
Publicado: (2022)

TLR7 Is Critical for Anti-Viral Humoral Immunity to EV71 Infection in the Spinal Cord
por: Lin, Ya-Lin, et al.
Publicado: (2021)

ICAMs are dispensable for influenza clearance and anti-viral humoral and cellular immunity
por: Kozlovski, Stav, et al.
Publicado: (2023)

Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression
por: Neupane, Biswas, et al.
Publicado: (2020)

Potential role of dengue virus, chikungunya virus and Zika virus in neurological diseases
por: Vieira, Marcelo Adriano da Cunha e Silva, et al.
Publicado: (2018)

A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection
por: Teng, Terk-Shin, et al.
Publicado: (2015)

The Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil
por: Zanotto, Paolo Marinho de Andrade, et al.
Publicado: (2018)

Granzyme A in Chikungunya and Other Arboviral Infections
por: Schanoski, Alessandra S., et al.
Publicado: (2020)

Disease Resolution in Chikungunya—What Decides the Outcome?
por: Srivastava, Priyanshu, et al.
Publicado: (2020)

Acute-Phase Levels of CXCL8 as Risk Factor for Chronic Arthralgia Following Chikungunya Virus Infection
por: Jacob-Nascimento, Leile Camila, et al.
Publicado: (2021)

VCP/p97 Is a Proviral Host Factor for Replication of Chikungunya Virus and Other Alphaviruses
por: Carissimo, Guillaume, et al.
Publicado: (2019)

The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity
por: Jenks, Jennifer A., et al.
Publicado: (2019)

Viral Circular RNAs and Their Possible Roles in Virus-Host Interaction
por: Zhang, Xing, et al.
Publicado: (2022)

Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model
por: Campos, Rafael Kroon, et al.
Publicado: (2020)

Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs
por: Ramos, Irene, et al.
Publicado: (2015)

Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2
por: Chan, Yi‐Hao, et al.
Publicado: (2021)

Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1
por: Kong, Yi-chi M., et al.
Publicado: (2014)

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus
por: López-Camacho, César, et al.
Publicado: (2019)

HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation
por: Duygu, Burcu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uspm8uu8jkf42suhjgd92nnmhe